Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease - Wikidata - wikimedia - TriplyDB

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

http://www.wikidata.org/entity/Q34802970

about

Sulforaphane as a potential protective phytochemical against neurodegenerative diseases The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.MRI and histopathologic study of a novel cholesterol-fed rabbit model of xanthogranuloma.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Reduced CSF turnover and decreased ventricular Aβ42 levels are related The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease.Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months.Alzheimer's disease and vascular deficiency: lessons from imaging studies and down syndrome.Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress.Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease.Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH.Imaging the Alzheimer brain.Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features.Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.Genetic variation modifies risk for neurodegeneration based on biomarker status.Ventricular and Periventricular Anomalies in the Aging and Cognitively Impaired Brain.An automated template-based adaptive threshold approach for measuring ventricular volume enlargement in mouse brain MR microscopy.Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain.Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus Particular CSF sphingolipid patterns identify iNPH and AD patients

P2860

Q21285068-1DFC2AB2-7136-4BC6-9065-FB67F3C5189C Q27006831-31F36281-EE84-4FE6-954F-1CBA3BD75C42 Q28728773-FF5E8FBA-FA95-47DA-AEA0-354D241752D4 Q30971403-4D305C94-6E75-4C6E-A2BA-433D150E100C Q31049589-6CE67485-5830-44E0-BF56-36270E1F02D6 Q33754677-A177263E-F2D9-4C14-89AF-BDDAC6565A8B Q33898968-2A7CD281-65C6-4A9E-99CC-5B9ECEE696EA Q34065449-1C699BFC-8D1D-4E8C-8E25-2125BD1D2F44 Q34493638-85100E99-5E8F-42C4-9644-93FDBDF6C917 Q35030119-FF4C8A0E-41C7-4578-9050-5395BAE35953 Q35276630-E9BFDC29-F94A-4096-A08E-3D386068EE25 Q35742280-8F2A900B-C5A6-4662-A0AA-266498C7603B Q35778854-45A9C70F-DF92-41FC-88EC-8176276E3DCF Q36115286-8A892A65-D481-445B-B910-37155EBD6B05 Q36160858-05A245F8-E0AA-4D83-BA92-2DE85A409FB8 Q36945742-32DC9FF9-0DED-48FB-B92E-97A45E9B64A3 Q37141502-05F8F9B6-82D9-4341-9BF0-A3E72183C766 Q37223911-49A33970-1D64-47BE-B65A-46F2A7560EF5 Q37524486-0C8001F5-3A69-400F-B275-F866353E8EB3 Q37616894-2F0C645F-0AF9-4EAA-A5B3-32DEC8FC05E2 Q37716145-02CC4E3F-ACDF-44CE-9927-BA93C563B4E2 Q39036392-FBF94C9C-079C-4E5D-A0D6-C7266534532F Q46000358-05D89F5C-8514-40B2-A29B-354B76A76A21 Q47833196-ED92E43A-C5E7-4252-B17E-7D8C2DC8AB47 Q48301740-81A94C6D-D9B2-4CB3-AD2A-20EA1FF50BC9 Q51000764-D0F67335-50AE-4489-B651-FDC95C50A682 Q51761053-3120D32F-A971-496C-930B-73F111D8698A Q58730162-4CDD640A-710C-45F4-A878-1ABC5AE4C8D4 Q58751934-6EEA002C-CDEB-4D6A-82F4-ADF62C171B94

P2860

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

http://www.wikidata.org/entity/Q34802970

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@ast

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@en

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@nl

type

label

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@ast

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@en

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@nl

prefLabel

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@ast

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@en

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@nl

P1433

Q34802970-CE27BA43-AE06-48BE-AEA1-D0716DDD2246

P1476

Q34802970-0646B09E-3507-4BAE-8BA6-8ADAE2122EA1

P2093

Q34802970-03403359-23FE-461F-8BEB-338FA6478C52

Q34802970-2A44E46D-223C-4EBD-A7B4-859BB14CAB4D

Q34802970-43CD05F2-BBBB-4CFB-8759-9096BBF066D9

Q34802970-8FF2136E-0776-4AD2-889A-EAA8C19B693F

Q34802970-C19F3BF2-37B2-410C-BC10-1EB83563623C

Q34802970-F6CB695F-84A4-4862-933A-8E1F41D10C4E

P2860

Q34802970-02AF7C13-125C-4FCE-BCFB-1046E7CE10EA

Q34802970-070C5F4F-685A-4B70-AADB-DCED201E9DE0

Q34802970-0A019DD4-8185-4E6A-B77A-930DE599528B

Q34802970-18F2C669-3F1E-4D48-AFC1-4CAB1C9E7F99

Q34802970-1ADE2D74-A145-4DF3-BAED-9296BEA302C8

Q34802970-280B4065-932D-4BA0-8A8E-493F007959AF

Q34802970-325FEE75-3CEB-410A-9598-1AFA13F19AE8

Q34802970-36954668-FEAF-405A-9E92-1704220973A4

Q34802970-36B3640F-749F-44E1-91E7-59B6E255BA35

Q34802970-38237414-F2C2-45EF-A96C-40250F175ED5

P304

Q34802970-8FB9457B-6A4D-426D-B6A7-E8529E61469A

P31

Q34802970-2B03E6C0-D86E-4C8D-AE8F-F1F36E135A75

P356

Q34802970-2CA968A2-48EC-4018-AD93-914B0FD49DA8

P433

Q34802970-45281935-C925-4587-B589-360C2D7B7315

P478

Q34802970-7E413660-3536-4E2A-8826-775C5DACBD51

P50

Q34802970-0DD65BE4-AFE3-4B89-91A2-A743BAA646E2

Q34802970-37558E06-630E-48ED-9596-BC37A39E793F

Q34802970-4BB7B902-768C-4852-B66E-9B90A9065D1E

P577

Q34802970-8364F2D2-7AE0-4388-95DD-6CA141A4B96F

P5875

Q34802970-6F220E05-2DFB-46D2-AA7F-E3CA2F4CA403

P698

Q34802970-2D9A5257-B085-4493-9D81-19E82E43746C

P921

Q34802970-3D65EADA-FE49-486C-AAE6-AEBCD25DEF12

Q34802970-9291E5F0-C7BE-4280-AF3F-9CFA9E7FE62F

Q34802970-ACE45DDD-A7F1-4A87-AFC8-C40DC93CD870

P932

Q34802970-53EC3932-04AE-46BE-976A-78520D918348

P356

P1433

Journal of Alzheimer's Disease

P1476

Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease

@en

P2093

Brian R Ott

http://www.w3.org/2001/XMLSchema#string

Edward G Stopa

http://www.w3.org/2001/XMLSchema#string

Gerald D Silverberg

http://www.w3.org/2001/XMLSchema#string

John E Donahue

http://www.w3.org/2001/XMLSchema#string

Ozioma C Okonkwo

http://www.w3.org/2001/XMLSchema#string

Ronald A Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostatic capabilities of the choroid plexus epithelium in Alzheimer's disease

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Cortical Surface-Based Analysis

Alzheimer's disease: the amyloid cascade hypothesis

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

The Alzheimer's disease neuroimaging initiative.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease

Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

P304

647-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-1406

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Assawin Gongvatana

Alzheimer's Disease Neuroimaging Initiative

Conrad Johanson

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41562353

http://www.w3.org/2001/XMLSchema#string

P698

20182051

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

3078034

http://www.w3.org/2001/XMLSchema#string